APR 03, 2016 12:16 PM PDT

Vaccine adjuvant fights infection

WRITTEN BY: Kerry Evans
Researchers from Vanderbilt University Medical Center found that a vaccine adjuvant could protect burn victims from infection.

The group found that the adjuvant monophosphoryl lipid A induces the production of granulocyte colony stimulating factor (G-CSF) to boost the production of infection-fighting neutrophils.
 
Vaccine adjuvant may protect against infection.

Lipid A is a component of lipopolysaccharide (LPS) found in Gram-negative bacteria; LPS induces a significant immune response during bacterial infection. Cells sense the presence of LPS using toll-like receptor 4, which signals the immune system that an infection is present.

Monophosphoryl lipid A (MPLA) is a component of many vaccines (anti-cancer vaccines, for example) where it is used to generate an immune response. In this application, the MPLA comes from Salmonella minnesota and has been tested in over 300,000 human subjects.

In a study published in the Journal of Leukocyte Biology, the Vanderbilt University researchers used a mouse model to test whether MPLA could help prevent infection in burn patients. They induced a burn injury in two groups of mice. One group received MPLA, and the other received only saline. The researchers then added Pseudomonas aeruginosa bacteria to the wounds and monitored how the infection spread. Mice treated with MPLA had fewer P. aeruginosa cells in their blood and lungs. They also had a higher rate of survival than saline-treated mice.

The researchers suspected that G-CSF helped stimulate neutrophils to fight infection after the mice were treated with MPLA. To test this, they blocked G-CSF production before treating the mice with MPLA. In this case, MPLA was not able to protect the mice, indicating an important role for G-CSF.

According to study author Julia Bohannon, “as a survivor of a severe burn injury myself, it is my ultimate hope that this study, and future studies that stem from these findings, will lead to effective interventions that will significantly reduce the incidence of deadly infections in burn patients, as well as other critically ill and injured patients".
 

Source: Journal of Leukocyte Biology, Lipid A in Cancer Therapy, EurekAlert, Wikipedia
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 17, 2019
Microbiology
OCT 17, 2019
The Therapeutic Potential of Bacteriophages
There are vast numbers of viruses in our world, and some of them, called bacteriophages, only infect bacteria....
OCT 17, 2019
Genetics & Genomics
OCT 17, 2019
Why are More Boys Born than Girls?
On average, there are 105 boys born for every 100 girls. Is it purely a genetic tendency or are there environmental factors at play too?  Back in 2008...
OCT 17, 2019
Microbiology
OCT 17, 2019
Researchers Reconstruct the HIV Genome From a Sample Taken in 1966
Now there is biological evidence that the virus infected people in Africa before it was identified in the US....
OCT 17, 2019
Genetics & Genomics
OCT 17, 2019
Gut Microbes can Significantly Impact Host Gene Expression
We all carry a vast number of microbes with us, and the microbial community in the gut is closely linked to our health and well-being....
OCT 17, 2019
Microbiology
OCT 17, 2019
A Mosquito-borne Disease Called EEE is Spreading This Year
Massachusetts health officials confirmed yesterday that a third person has died from Eastern Equine Encephalitis this year....
OCT 17, 2019
Microbiology
OCT 17, 2019
Raising Awareness of Valley Fever
Valley fever primarily occurs in Arizona and California, and infects around 10,000 people every year....
Loading Comments...